Literature DB >> 24068612

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: summary.

Jawl-Shan Hwang1, Ding-Cheng Chan, Jung-Fu Chen, Tien-Tsai Cheng, Chih-Hsing Wu, Yung-Kuei Soong, Keh-Sung Tsai, Rong-Sen Yang.   

Abstract

Osteoporosis is recognized as a major public health problem worldwide and in Taiwan. However, many patients with osteoporotic fractures do not receive appropriate assessments or treatments. This guideline, proposed by the Taiwanese Osteoporosis Association, is to serve as a quick reference for healthcare providers to improve the assessment of osteoporosis and development of optimal strategies for osteoporotic management in Taiwan. To review and update osteoporosis management, the guideline is constituted with Taiwan-specific osteoporosis epidemiological data, medication protocols, and the 10-year FRAX(®). The guideline is based on evidence-based medicine and public health considerations. Recommendations are not limited to the reimbursement regulations permitted by the National Health Insurance of Taiwan.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24068612     DOI: 10.1007/s00774-013-0495-0

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  29 in total

1.  The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis.

Authors:  Jawl-Shan Hwang; Lin-Show Chin; Jung-Fu Chen; Tzay-Shing Yang; Po-Quang Chen; Keh-Sung Tsai; Ping Chung Leung
Journal:  J Bone Miner Metab       Date:  2010-10-05       Impact factor: 2.626

2.  International Society for Clinical Densitometry official positions: Asia-Pacific Region consensus.

Authors:  Annie W C Kung; Chih-Hsing Wu; Akira Itabashi; Joon Kiong Lee; Hyoung Moo Park; Yanling Zhao; Wing P Chan; David L Kendler; Edward S Leib; E Michael Lewiecki; John P Bilezikian; Sanford Baim
Journal:  J Clin Densitom       Date:  2010-07-21       Impact factor: 2.617

3.  The effects of strontium ranelate in Asian women with postmenopausal osteoporosis.

Authors:  J S Hwang; J F Chen; T S Yang; D J Wu; K S Tsai; C Ho; C H Wu; S L Su; C J Wang; S T Tu
Journal:  Calcif Tissue Int       Date:  2008-10-09       Impact factor: 4.333

4.  Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Authors:  J R Center; T V Nguyen; D Schneider; P N Sambrook; J A Eisman
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

5.  Bone mineral density in adults in Taiwan: results of the Nutrition and Health Survey in Taiwan 2005-2008 (NAHSIT 2005-2008).

Authors:  Yi-Chin Lin; Wen-Harn Pan
Journal:  Asia Pac J Clin Nutr       Date:  2011       Impact factor: 1.662

6.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

7.  Estimated prevalence of osteoporosis from a Nationwide Health Insurance database in Taiwan.

Authors:  Nan-Ping Yang; Chung-Yeh Deng; Yiing-Jenq Chou; Po-Quang Chen; Ching-Heng Lin; Pesus Chou; Hong-Jen Chang
Journal:  Health Policy       Date:  2005-06-08       Impact factor: 2.980

Review 8.  Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

Authors:  Benjamin M P Tang; Guy D Eslick; Caryl Nowson; Caroline Smith; Alan Bensoussan
Journal:  Lancet       Date:  2007-08-25       Impact factor: 79.321

9.  A nationwide seven-year trend of hip fractures in the elderly population of Taiwan.

Authors:  Chung-Jung Shao; Yu-Hsiang Hsieh; Ching-Hui Tsai; Kuo-An Lai
Journal:  Bone       Date:  2008-09-20       Impact factor: 4.398

10.  Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.

Authors:  Catherine MacLean; Sydne Newberry; Margaret Maglione; Maureen McMahon; Veena Ranganath; Marika Suttorp; Walter Mojica; Martha Timmer; Alicia Alexander; Melissa McNamara; Sheetal B Desai; Annie Zhou; Susan Chen; Jason Carter; Carlo Tringale; Di Valentine; Breanne Johnsen; Jennifer Grossman
Journal:  Ann Intern Med       Date:  2007-12-17       Impact factor: 25.391

View more
  33 in total

1.  Budget impact analysis of osteoporosis medications for primary prevention of fractures in Taiwan.

Authors:  Kun-Ling Wu; Chih-Hsing Wu; Yin-Fan Chang; Yun-Ting Lin; Jason C Hsu
Journal:  J Bone Miner Metab       Date:  2019-11-11       Impact factor: 2.626

2.  Risk of osteoporosis and fracture in victims with burn injury.

Authors:  O Kaewboonchoo; F C Sung; C L Lin; H C Hsu; C T Kuo
Journal:  Osteoporos Int       Date:  2019-02-08       Impact factor: 4.507

3.  Age- and sex-specific concentrations of bone remodeling markers in healthy Indian adults with and without vitamin D deficiency.

Authors:  Rimesh Pal; Anshita Aggarwal; Naresh Sachdeva; Sant Ram; Abhilasha Garg; Anil Bhansali; Sanjay Kumar Bhadada
Journal:  Arch Osteoporos       Date:  2021-01-07       Impact factor: 2.617

4.  Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold.

Authors:  Y Wang; S Yu; C Hsu; C Tsai; T Cheng
Journal:  Osteoporos Int       Date:  2019-11-06       Impact factor: 4.507

Review 5.  A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia.

Authors:  J F Chen; K H Yang; Z L Zhang; H C Chang; Y Chen; H Sowa; S Gürbüz
Journal:  Osteoporos Int       Date:  2014-08-20       Impact factor: 4.507

6.  Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.

Authors:  X Huang; B Chen; L Thabane; J D Adachi; G Li
Journal:  Osteoporos Int       Date:  2021-02-17       Impact factor: 4.507

Review 7.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

8.  Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals.

Authors:  V C Kok; J-T Horng; M N Wang; Z-Y Chen; J-T Kuo; G-D Hung
Journal:  Osteoporos Int       Date:  2018-01-30       Impact factor: 4.507

Review 9.  Secondary prevention of fragility fractures in Asia Pacific: an educational initiative.

Authors:  P R Ebeling; D-C Chan; T C Lau; J K Lee; T Songpatanasilp; S H Wong; F L Hew; R Sethi; M Williams
Journal:  Osteoporos Int       Date:  2019-12-01       Impact factor: 4.507

10.  Novel algorithm generating strategy to identify high fracture risk population using a hybrid intervention threshold.

Authors:  Chung-Yuan Hsu; Chih-Hsing Wu; Shan-Fu Yu; Yu-Jih Su; Wen-Chan Chiu; Ying-Chou Chen; Han-Ming Lai; Jia-Feng Chen; Chi-Hua Ko; Jung-Fu Chen; Tien-Tsai Cheng
Journal:  J Bone Miner Metab       Date:  2019-10-03       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.